Skip to main content

Table 1 Characteristics of studies included in the meta-analysis

From: The contribution of the ABCG2 C421A polymorphism to cancer susceptibility: a meta-analysis of the current literature

First author

Year

Country

Ethnicity

Cancer type

Source of controls

Cases

Controls

Case

Control

HWE

        

CC

CA

AA

CC

CA

AA

 

Andersen[29]

2009

Denmark

Caucasian

Colorectal cancer

PB

359

765

296

58

5

592

161

12

0.782

Campa[31]

2008

Germany

Caucasian

Colorectal cancer

HB

582

517

472

103

7

409

104

4

0.347

Campa[30]

2011

Germany

Caucasian

Lymphoma

HB

1067

1196

898

158

11

957

229

10

0.359

Campa[30]

2011

Germany

Caucasian

Lymphoma

HB

259

1156

224

33

2

921

221

14

0.856

Hu[33]

2007

China

Asian

Lymphoma

MIXED

156

376

60

80

16

181

162

33

0.703

Campa[30]

2011

Germany

Caucasian

Leukemia

HB

321

1196

284

33

4

957

229

10

0.359

Muller[35]

2008

Germany

Caucasian

Leukemia

HB

110

179

100

10

0

160

18

1

0.532

Semsei[36]

2008

Hungary

Caucasian

Leukemia

HB

369

149

294

72

3

121

28

0

0.206

Korenaga[34]

2005

Japan

Asian

Renal cell carcinoma

PB

200

200

124

60

16

92

91

17

0.405

Gardner[32]

2008

America

Caucasian

Prostate cancer

PB

170

141

142

27

1

111

27

3

0.384

  1. PB: population based; HB: hospital based; MIXED: population based and hospital based.